Max Robotics — Global Service Robot Directory + US Certification

About

Michael D. Fabrizio is a urological surgeon and researcher whose work has significantly advanced the understanding and practice of minimally invasive treatment for localized prostate cancer. His research focuses primarily on robotic-assisted laparoscopic radical prostatectomy (RALRP), surgical oncology outcomes, and health-related quality of life (HRQoL) following prostate cancer treatment. Fabrizio's most impactful contribution is his leadership of a landmark multi-institutional study examining positive surgical margins across 8,418 robotic prostatectomies, garnering 149 citations and providing critical guidance on surgical technique and oncologic outcomes. Complementing this, his comparative HRQoL research across four treatment modalities—including open surgery, robotic prostatectomy, cryoablation, and brachytherapy—has earned over 100 citations, offering patients and clinicians nuanced insight into functional recovery trajectories. His technical innovations, including a modified vesicourethral anastomosis technique and posterior reconstruction strategies to accelerate continence recovery, reflect a commitment to refining surgical precision. His early prospective longitudinal studies evaluating five surgical approaches from a single institution further established his reputation as a pioneer in patient-centered outcomes research. Across his body of work, Fabrizio has helped shape modern robotic prostate surgery into a safer, better-understood intervention for thousands of patients.